TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05755178

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music, feelings and relationships - music group for children at shelters
Description: A music group intervention, offered to children 3-10 years who live or have lived at a shelter.~6 group sessions with musicians and music therapist and a group of 4-8 children.~Focus on improving recognition and regulation of emotions, and on relational capacity with adults and peers.
Study: NCT05518188

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MELPIDA
Description: MELPIDA, a recombinant serotype 9 adeno-associated virus (AAV) encoding a codon-optimized human AP4M1 transgene
Study: NCT05853640

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care at the orthopedic department consists of a clinical examination, radiological imaging, and a diagnostic injection. A recommendation to get physical therapy treatment in primary care will be provided, but this intervention will not be controlled by the investigators in any capacity.
Study: NCT04167111

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cholecalciferol
Description: Vitamin D

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cholecalciferol
Description: Vitamin D
Study: NCT04974749

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: REPLAGAL
Description: REPLAGAL IV infusion.
Study: NCT05065710

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZL-1211
Description: Phase 1 dose escalation part will enroll about 12-42 patients, Phase 2 dose expansion part will enroll about 15-40 patients in each cohort
Study: NCT06581367

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tailoring the course duration to the patient's needs.
Description: Patients will be advised to visit the center as soon as they feel better and are afebrile for a clinical assessment including vital signs (temperature, blood pressure, respiratory rate, pulse, and oxygen saturation) and C-reactive protein rapid testing after completing two full days of antibiotic.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Complete a 7-day course
Description: The antibiotic course must be completed (7 days at least).
Study: NCT06260969

Intervention type: DEVICE
Intervention: balloon dilatation
Description: Direct balloon dilation vs stenting vs embolectomy + tirofiban vs embolectomy + balloon dilation vs embolectomy + balloon dilation + intracranial stenting
Study: NCT05332418

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: selected exercise program
Description: therapeutic ultrasound, Static neck exercise, Educational postural correction, and Home neck exercise program for patient

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: selected exercise program
Description: therapeutic ultrasound, Static neck exercise, Educational postural correction, and Home neck exercise program for patient

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electromagenetic Field therapy
Description: Magnetotherapy application the device will be adjusted around the neck and shoulder area at low frequency (50 Hz), with intensity of 2.5 MT, field shape and applicator type rectangular csl60/csp60) , and the application time (10 minutes)
Study: NCT06437912

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botulinum toxin type A
Description: Eligible patients were randomly assigned to the experimental group and the control group. Patients in the experimental group will be randomized to receive injections of 1 U,2.5 U, and 5 U botulinum toxin type A,Patients in the control group received an injection of 0.9% Nacl

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Description: Eligible patients were randomly assigned to the experimental group and the control group. Patients in the experimental group will be randomized to receive injections of 1 U,2.5 U, and 5 U botulinum toxin type A,Patients in the control group received an injection of 0.9% Nacl

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Description: Eligible patients were randomly assigned to the experimental group and the control group. Patients in the experimental group will be randomized to receive injections of 1 U,2.5 U, and 5 U botulinum toxin type A,Patients in the control group received an injection of 0.9% Nacl

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Description: Eligible patients were randomly assigned to the experimental group and the control group. Patients in the experimental group will be randomized to receive injections of 1 U,2.5 U, and 5 U botulinum toxin type A,Patients in the control group received an injection of 0.9% Nacl
Study: NCT04721340

Intervention type: OTHER
Intervention: Test Group
Description: Individuals who meet the inclusion criteria will be evaluated for manual dexterity, performance, muscle strength and fatigue, respectively, on a predetermined day.

Intervention type: OTHER
Intervention: Control Grup
Description: Individuals who meet the inclusion criteria will be evaluated for manual dexterity, performance, muscle strength and fatigue, respectively, on a predetermined day.
Study: NCT06030284

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BurstDR-SCS
Description: Spinal Cord Stimulation with a BurstDR-SCS system.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BurstDR-SCS
Description: BurstDR-SCS system turned off.
Study: NCT04667416

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PalinGen Flow Amniotic Tissue Allograft
Description: Participants will receive wound size-dependent dose of PalinGen Flow liquid human amniotic tissue allograft by subcutaneous injection in addition to SOC.
Study: NCT06582966

Intervention type: DRUG
Group type: OTHER
Intervention: Doxycyclin
Description: Open label, single-arm, pilot study of 60 cisgender women taking HIV PrEP in Kisumu, Kenya will be given doxycycline 200 mg orally once weekly with clinical follow-up including quarterly STI testing and treatment for six months.
Study: NCT05298800

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Vaccine
Description: Different arms were administrated different vaccines

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Vaccine
Description: Different arms were administrated different vaccines

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Vaccine
Description: Different arms were administrated different vaccines
Study: NCT05294458

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cotadutide solution for injection
Description: cotadutide solution for injection
Study: NCT04836988

Intervention type: OTHER
Intervention: Three months of digitally delivered osteoarthritis treatment
Description: Digitally delivered osteoarthritis management including education and exercise and weight control if needed
Study: NCT05853640

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HIPSTER
Description: Patients will be provided with usual care at the orthopedic department, which consists of a clinical examination, radiological imaging, and a diagnostic injection.~In addition, participants in this group will be referred to physical therapists trained in administering a semi-structured, individualized, progressive treatment. This 16-week intervention targets known physical and psychological impairments in people with long-standing hip and groin pain, using exercise therapy and patient education.
Study: NCT04836988

Intervention type: OTHER
Intervention: Three months of face-to-face delivered osteoarthritis treatment
Description: Face-toface delivered osteoarthritis management including education and exercise and weight control if needed
Study: NCT05829863

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: educational message exposure
Description: Exposing African American young adult vapers to persuasive anti-vaping public service announcements (PSAs) with the goal of reducing their subsequent e-cigarette use.
Study: NCT06225830

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Eksobionics Eksoskeleton NR
Description: During treatment sessions, the therapist will guide the participant's progress using a specific plan. The therapist will set a trajectory for each leg, determining the appropriate step height and length, and program it into the Ekso device. The Ekso will then assist the participant by following this trajectory, with varying levels of assistance for each step. As the participant improves, the therapist will gradually reduce the assistance provided until the participant reaches a point where they no longer require assistance or reach a plateau. In the final phase, the trajectory will be removed, and the participant will walk using their own movements. The therapist may add resistance or assistance based on the participant's needs, but it will be in line with their self-generated movements rather than a predetermined path.
Study: NCT06428175

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Focused Dose Hospital-to-Home Transitional Care Interventions
Description: Focused dose H2H-TCIs will consist of a one-time post-discharge phone call completed within 72 hours post-hospital discharge by a clinical interventionist (e.g., nurse care coordinator or care manager). Calls will follow a structured template that provides empirically supported core H2H-TCI functions (follow-up care access, contingency planning, medication review, family education). The interventionist will also conduct a pre-hospital discharge clinical needs assessment with the parent.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Extended Dose Hospital-to-Home Transitional Care Interventions
Description: Extended dose H2H-TCIs will include a pre-discharge clinical needs assessment and initial phone call within 72 hours post-discharge, similar to the focused arm. After the initial contact, the dose of the extended H2H-TCI will increase as subjects receive high-intensity support during weekly post-discharge phone contacts through 30 days post-discharge. All contacts in the extended dose arm will be completed by a transition coach interventionist (e.g., nurse care coordinator or care manager) who will be formally trained on pillars of the Care Transitions Intervention© (CTI), a multi-faceted H2H-TCI that is the basis for the extended dose arm.
Study: NCT06198946

Intervention type: DEVICE
Group type: OTHER
Intervention: External diaphragm pacing（EDP）
Description: After the skin is disinfected, place the small electrode pads on the lower 1/3 of the outer edges of the sternocleidomastoid muscles on the left and right sides, and place the large electrodes on the surface of the pectoralis major muscles on both sides, and fix them with medical tape. Adjust the pacing according to the patient's tolerance. Frequency and stimulation intensity, each treatment time is 20 minutes, treatment is once a day, 5 days a week, and the treatment course is 4 weeks.

Intervention type: OTHER
Group type: OTHER
Intervention: Routine rehabilitation treatment
Description: Participants received comprehensive rehabilitation treatments such as muscle strength training, hemiplegic limb comprehensive training, balance function training, limb neuromuscular electrical stimulation, acupuncture and other comprehensive rehabilitation treatments. Each project was 30 minutes/time, once a day, 5 days a week, and the treatment course was 4 weeks.comprehensive rehabilitation treatments, each item is 30 minutes/time, once a day, 5 days a week, and the treatment course is 4 weeks.

Intervention type: OTHER
Group type: OTHER
Intervention: Routine rehabilitation treatment
Description: Participants received comprehensive rehabilitation treatments such as muscle strength training, hemiplegic limb comprehensive training, balance function training, limb neuromuscular electrical stimulation, acupuncture and other comprehensive rehabilitation treatments. Each project was 30 minutes/time, once a day, 5 days a week, and the treatment course was 4 weeks.comprehensive rehabilitation treatments, each item is 30 minutes/time, once a day, 5 days a week, and the treatment course is 4 weeks.
Study: NCT06421363

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inclisiran
Description: Implementation of a follow-up program that incorporates Inclisiran treatment in patients with a history of chronic coronary syndrome
Study: NCT05081128

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: programmable CSF shunt valve
Description: Brain shunt surgery using a programmable CSF shunt valve

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: programmable CSF shunt valve
Description: Brain shunt surgery using a programmable CSF shunt valve
Study: NCT05273294

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Portable color Doppler ultrasound system
Description: In the ultrasound group, the catheter type was selected according to the results of ultrasonic measurement of transverse diameter of cricoid cartilage after induction of general anesthesia, and tracheal intubation was performed with ordinary laryngoscope after measurement
Study: NCT05911893

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: high caloric oral nutritional supplements
Description: High caloric oral nutritional supplements (which can supplement 30% of the energy requirement) is given daily, and the recommended amount of energy and protein is referred to the 2013 Chinese Dietary Nutrient Reference Intake Table. At 6 months of enrollment, participants will be asked to evaluate whether to continue feeding according to the experimental group protocol or to stop to ensure proper nutritional intake.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: nutritional education
Description: After enrollment,health education information is pushed approximately every 4 weeks through the WeChat platform or/and short text messages to parents.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: nutritional education
Description: After enrollment,health education information is pushed approximately every 4 weeks through the WeChat platform or/and short text messages to parents.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: dietary guidance
Description: At follow-up visits at 0, 1, 2, 3, 6,and 12 months after enrollment, a professionally trained pediatrician give the participant's guardian dietary instructions appropriate to the age stage and physical condition of the child. Each session lasts approximately 10 minutes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: dietary guidance
Description: At follow-up visits at 0, 1, 2, 3, 6,and 12 months after enrollment, a professionally trained pediatrician give the participant's guardian dietary instructions appropriate to the age stage and physical condition of the child. Each session lasts approximately 10 minutes.
Study: NCT05762224

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effect of kinesio taping on upper limb lymphedema
Description: Group A received Kinesio taping 2 times a week for 3 weeks to reduce lymphedema and Group B received pressure garments(20-60 mm Hg) for at least 15 to 18 hours per day for 3 weeks

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Effect of kinesio taping on upper limb lymphedema
Description: Group A received Kinesio taping 2 times a week for 3 weeks to reduce lymphedema and Group B received pressure garments(20-60 mm Hg) for at least 15 to 18 hours per day for 3 weeks
Study: NCT05046691

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 8-week mindfulness program
Description: The .b Foundations course is an 8-week mindfulness program developed by Mindfulness in Schools Project (MiSP) for school teachers and personnel. It includes a taster session and 8 weekly sessions. Each session lasts for 1.5 hours with a specific theme (e.g. Lesson 1 waking up from autopilot). Formal and informal mindfulness practices (e.g. mindful eating, body scan, mindful walking, habit releaser etc.), psychoeducation, cognitive exercises, inquiry, and home practice are involved.
Study: NCT05203159

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ocean sound
Description: The experimental group will listen to ocean sound, starting at the 1st minute before the ROP examination and ending at the 5th minute after the ROP examination.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine
Description: No sound will be played before, during and after the ROP examination.
Study: NCT05321368

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LINKED-HEARTS Program
Description: The intervention arm will include training on home blood pressure monitoring, Sphygmo blood pressure telemonitoring app, Community Health Worker visit for education, counseling on lifestyles modification and Pharmacist to collaborate with other providers to optimize pharmacologic therapy to improve hypertension outcomes and with payors to ensure consistent access to drug therapy.
Study: NCT06099444

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional High Intensity Gait Training
Description: Participants during a training session will complete at least 30 minutes of treadmill walking at the target intensity. The participants will complete 18 training sessions.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard FES to the Tibialis Anterior (TA)
Description: Participants during a training session will complete at least 30 minutes of treadmill walking at the target intensity while wearing a FES stimulator on the tibialis anterior muscle of their more affected leg. Stimulation will be triggered prior to swing phase to combat drop foot. The participants will complete 18 training sessions.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Synergy-Based Multichannel FES (MFES)
Description: Participants during a training session will complete at least 30 minutes of treadmill walking at the target intensity while FES is applied to multiple muscles of the leg throughout the gait cycle based on the healthy muscle synergies. The goal will be to have the FES applied for at least 20 minutes of each gait training session. The participants will complete 18 training sessions.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Synergy-Based Multichannel FES (MFES)
Description: Participants during a training session will complete at least 30 minutes of treadmill walking at the target intensity while FES is applied to multiple muscles of the leg throughout the gait cycle based on the healthy muscle synergies. The goal will be to have the FES applied for at least 20 minutes of each gait training session. The participants will complete 18 training sessions.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Muscle Synergy Visual Biofeedback
Description: Participants during a training session will complete at least 30 minutes of treadmill walking at the target intensity while receiving visual feedback of the similarity of their muscle synergies to healthy muscle synergies. They will be instructed to try to optimize the similarity score. The participants will complete 18 training sessions.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Muscle Synergy Visual Biofeedback
Description: Participants during a training session will complete at least 30 minutes of treadmill walking at the target intensity while receiving visual feedback of the similarity of their muscle synergies to healthy muscle synergies. They will be instructed to try to optimize the similarity score. The participants will complete 18 training sessions.
Study: NCT04633200

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DOT mobile app
Description: DOT is a mobile phone app that has daily pill reminders and supportive texts, as well as various features designed to support PrEP medication adherence.
Study: NCT06073587

Intervention type: DIAGNOSTIC_TEST
Intervention: Scintigraphy scan
Description: Scans will be performed as specified in the arm description.
Study: NCT06222489

Intervention type: DRUG
Group type: OTHER
Intervention: 89Zr-Patritumab deruxtecan
Description: Day 1, day 3, day 6, day 11 and day 26 of first course
Study: NCT04150692

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dara-SC
Description: -Subcutaneous daratumumab and hyaluronidase-fihj

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Dara-SC
Description: -Subcutaneous daratumumab and hyaluronidase-fihj

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood for research assessments
Description: -Cycle 1 Day 1, Cycle 3 Day 1, and at progression or end of study (whichever is first)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Blood for research assessments
Description: -Cycle 1 Day 1, Cycle 3 Day 1, and at progression or end of study (whichever is first)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone marrow for research assessments
Description: -Cycle 1 Day 1, Cycle 3 Day 1, and at progression or end of study (whichever is first)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone marrow for research assessments
Description: -Cycle 1 Day 1, Cycle 3 Day 1, and at progression or end of study (whichever is first)
Study: NCT05996900

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Intracranial electrodes
Description: Intracranial electrodes will be used for the delivery of invasive brain stimulation.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intracranial electrodes
Description: Intracranial electrodes will be used for the delivery of invasive brain stimulation.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: TMS
Description: TMS will be used for the delivery of noninvasive brain stimulation both before and after implantation electrode surgery.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TMS
Description: TMS will be used for the delivery of noninvasive brain stimulation both before and after implantation electrode surgery.
Study: NCT04885205

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive behavioral therapy for insomnia (CBT-I)
Description: The CBT-I program is a 6-week, 1x/week, one-on-one program. The delivery of CBT-I will be done remotely over a secure teleconference service (Zoom) or phone. Participants will maintain a sleep diary during the course of the program to aid in tailoring the intervention. Each session lasts about 45-60min:

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: cognitive behavioral therapy for insomnia (CBT-I)
Description: The CBT-I program is a 6-week, 1x/week, one-on-one program. The delivery of CBT-I will be done remotely over a secure teleconference service (Zoom) or phone. Participants will maintain a sleep diary during the course of the program to aid in tailoring the intervention. Each session lasts about 45-60min:
Study: NCT05869240

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BPB-101
Description: Subjects will receive an intravenous infusion of BPB-101 in a pre-set dose escalation until confirmed progression, unaccepted toxicity, or any criterion for withdrawal from the trial.